{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T15:40:27Z","timestamp":1791733227980,"version":"4.3.4"},"reference-count":76,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,6,11]],"date-time":"2019-06-11T00:00:00Z","timestamp":1560211200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["M\u00e9diterran\u00e9e Infection 10-IAHU-03"],"award-info":[{"award-number":["M\u00e9diterran\u00e9e Infection 10-IAHU-03"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Infect. Microbiol."],"DOI":"10.3389\/fcimb.2019.00193","type":"journal-article","created":{"date-parts":[[2019,6,11]],"date-time":"2019-06-11T04:59:46Z","timestamp":1560229186000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":85,"title":["Drug Repurposing to Fight Colistin and Carbapenem-Resistant Bacteria"],"prefix":"10.3389","volume":"9","author":[{"given":"Lucie","family":"Peyclit","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie Alexandra","family":"Baron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Marc","family":"Rolain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,6,11]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1038\/nrd1468","article-title":"Drug repositioning: identifying and developing new uses for existing drugs","volume":"3","author":"Ashburn","year":"2004","journal-title":"Nat. Rev. Drug Discov."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.2147\/IDR.S173867","article-title":"Antibiotic resistance: a rundown of a global crisis","volume":"11","author":"Aslam","year":"2018","journal-title":"Infect. Drug Resist."},{"key":"B3","doi-asserted-by":"publisher","first-page":"348","DOI":"10.3389\/fcimb.2018.00348","article-title":"synergistic activity of niclosamide in combination with colistin against colistin-susceptible and colistin-resistant Acinetobacter baumannii and Klebsiella pneumoniae","volume":"8","author":"Ayerbe-Algaba","year":"2018","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"B4","unstructured":"AzvolinskyA.\n          Repurposing existing drugs for new indications. The Scientist2017"},{"key":"B5","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1089\/mdr.2016.0323","article-title":"Occurrence of Carbapenemase-producing Enterobacteriaceae isolates in the wildlife: first report of OXA-48 in wild boars in Algeria","volume":"24","author":"Bachiri","year":"2017","journal-title":"Microb. Drug Resist."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1007\/s00134-017-4878-x","article-title":"Antimicrobial resistance in the next 30 years, humankind, bugs and drugs: a visionary approach","volume":"43","author":"Bassetti","year":"2017","journal-title":"Intensive Care Med."},{"key":"B7","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1586\/eri.12.78","article-title":"Colistin: an update on the antibiotic of the 21st century","volume":"10","author":"Biswas","year":"2012","journal-title":"Expert Rev. Anti. Infect. Ther."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.3389\/fmicb.2018.01808","article-title":"Synergistic activity of colistin in combination with resveratrol against colistin-resistant gram-negative pathogens","volume":"9","author":"Cannatelli","year":"2018","journal-title":"Front. Microbiol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"e69646","DOI":"10.1371\/journal.pone.0069646","article-title":"Toward repurposing ciclopirox as an antibiotic against drug-resistant Acinetobacter baumannii, Escherichia coli, and Klebsiella pneumoniae","volume":"8","author":"Carlson-Banning","year":"2013","journal-title":"PLoS ONE"},{"key":"B10","doi-asserted-by":"publisher","first-page":"551","DOI":"10.3389\/fmicb.2014.00551","article-title":"A new strategy to fight antimicrobial resistance: the revival of old antibiotics","volume":"5","author":"Cassir","year":"2014","journal-title":"Front. Microbiol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"363","DOI":"10.3389\/fcimb.2018.00363","article-title":"In vitro Activity of pentamidine alone and in combination with aminoglycosides, tigecycline, rifampicin, and doripenem against clinical strains of carbapenemase-producing and\/or colistin-resistant Enterobacteriaceae","volume":"8","author":"Cebrero-Cangueiro","year":"2018","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"2107","DOI":"10.2174\/1568026616666160216155556","article-title":"Scaffold repurposing of old drugs towards new cancer drug discovery","volume":"16","author":"Chen","year":"2016","journal-title":"Curr. Top. Med. Chem."},{"key":"B13","doi-asserted-by":"publisher","first-page":"438","DOI":"10.3389\/fcimb.2018.00438","article-title":"Repurposing screen identifies unconventional drugs with activity against multidrug resistant Acinetobacter baumannii","volume":"8","author":"Cheng","year":"2019","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1155\/2005\/892058","article-title":"Where are all the new antibiotics? The new antibiotic paradox","volume":"16","author":"Conly","year":"2005","journal-title":"Can. J. Infect. Dis. Med. Microbiol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1128\/AAC.01296-18","article-title":"Identification of FDA-approved drugs as antivirulence agents targeting the pqs quorum-sensing system of Pseudomonas aeruginosa","volume":"24","author":"D'Angelo","year":"2018","journal-title":"Antimicrob. Agents Chemother"},{"key":"B16","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.jhin,.2017.02.001","article-title":"Is faecal microbiota transplantation an option to eradicate highly drug-resistant enteric bacteria carriage?","volume":"95","author":"Davido","year":"2017","journal-title":"J. Hosp. Infect."},{"key":"B17","first-page":"3687","article-title":"Treatment for diabetes with sulfamide hypoglycemic agents","volume":"6","author":"Deuil","year":"1956","journal-title":"Rev. Prat."},{"key":"B18","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1586\/eri.13.1","article-title":"Investigation of antibiotic resistance in the genomic era of multidrug-resistant gram-negative bacilli, especially Enterobacteriaceae Pseudomonas Acinetobacter","volume":"11","author":"Diene","year":"2013","journal-title":"Expert Rev. Anti. Infect. Ther."},{"key":"B19","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/B978-0-12-386009-5.00004-7","article-title":"The future of drug repositioning: old drugs, new opportunities","volume":"46","author":"Doan","year":"2011","journal-title":"Annu. Rep. Med. Chem."},{"key":"B20","doi-asserted-by":"publisher","first-page":"e12693","DOI":"10.1111\/cmi.12693","article-title":"CRISPR\/Cas9-The ultimate weapon to battle infectious diseases?","volume":"19","author":"Doerflinger","year":"2017","journal-title":"Cell. Microbiol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1007\/s10096-011-1220-3","article-title":"Zidovudine (AZT) has a bactericidal effect on enterobacteria and induces genetic modifications in resistant strains","volume":"30","author":"Dol\u00e9ans-Jordheim","year":"2011","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1111\/jphp.12815","article-title":"Drug repurposing may generate novel approaches to treating depression","volume":"69","author":"Ebada","year":"2017","journal-title":"J. Pharm. Pharmacol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1128\/aac.31.2.274","article-title":"Antibacterial activity and mechanism of action of 3'-azido-3'-deoxythymidine (BW A509U)","volume":"31","author":"Elwell","year":"1987","journal-title":"Antimicrob. Agents Chemother."},{"key":"B24","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/J.BCP.2016.09.025","article-title":"Antibiotics in late clinical development","volume":"133","author":"Fernandes","year":"2017","journal-title":"Biochem. Pharmacol."},{"key":"B25","unstructured":"2019"},{"key":"B26","doi-asserted-by":"publisher","first-page":"eaat7520","DOI":"10.1126\/scitranslmed.aat7520","article-title":"Gallium disrupts bacterial iron metabolism and has therapeutic effects in mice and humans with lung infections","volume":"10","author":"Goss","year":"2018","journal-title":"Sci. Transl. Med."},{"key":"B27","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1093\/jac\/dkv484","article-title":"Antibiotics: from prehistory to the present day","volume":"71","author":"Gould","year":"2016","journal-title":"J. Antimicrob. Chemother."},{"key":"B28","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1128\/AAC.00292-17","article-title":"Susceptibility of colistin-resistant, gram-negative bacteria to antimicrobial peptides and ceragenins","volume":"25","author":"Hashemi","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"B29","doi-asserted-by":"publisher","first-page":"316","DOI":"10.3389\/fcimb.2018.00316","article-title":"Antimicrobial activity of gallium compounds on ESKAPE pathogens","volume":"8","author":"Hijazi","year":"2018","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1002\/wsbm.1337","article-title":"In silico methods for drug repurposing and pharmacology","volume":"8","author":"Hodos","year":"2016","journal-title":"Wiley Interdiscip. Rev. Syst. Biol. Med."},{"key":"B31","unstructured":"HuY.\n            CoatesP. A.\n          Combination Comprising Zidovudine and Polymyxin2014"},{"key":"B32","doi-asserted-by":"publisher","first-page":"e01630","DOI":"10.1128\/AAC.01630-18","article-title":"Azidothymidine produces synergistic activity in combination with colistin against antibiotic-resistant Enterobacteriaceae","volume":"63","author":"Hu","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"B33","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1089\/mdr.2016.0196","article-title":"From breast cancer to antimicrobial: combating extremely resistant gram-negative "superbugs" using novel combinations of polymyxin B with selective estrogen receptor modulators","volume":"23","author":"Hussein","year":"2017","journal-title":"Microb. Drug Resist."},{"key":"B34","unstructured":"JungM.-L.\n            ContrerasJ.-M.\n            MoriceC.\n            SimonJ.-M.\n            DidierB.\n            LangerT.\n          The Prestwick Chemical Library : a valuable tool for screening1997"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1093\/cid\/ciy378","article-title":"Difficult-to-treat resistance in gram-negative bacteremia at 173 US hospitals: retrospective cohort analysis of prevalence, predictors, and outcome of resistance to all first-line agents","volume":"67","author":"Kadri","year":"2018","journal-title":"Clin. Infect. Dis."},{"key":"B36","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1007\/s13311-014-0325-7","article-title":"Drug repositioning approaches for the discovery of new therapeutics for Alzheimer's disease","volume":"12","author":"Kim","year":"2015","journal-title":"Neurotherapeutics"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1016\/J.DRUDIS.2015.05.001","article-title":"Drug repositioning and repurposing: terminology and definitions in literature","volume":"20","author":"Langedijk","year":"2015","journal-title":"Drug Discov. Today"},{"key":"B38","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1016\/j.coi.2013.08.004","article-title":"Drug repurposing: a better approach for infectious disease drug discovery?","volume":"25","author":"Law","year":"2013","journal-title":"Curr. Opin. Immunol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.ijantimicag,.2016.09.014","article-title":"Synergistic combinations of polymyxins","volume":"48","author":"Lenhard","year":"2016","journal-title":"Int. J. Antimicrob. Agents"},{"key":"B40","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1093\/jac\/25.4.706","article-title":"Zidovudine-resistance in salmonella typhimurium and Escherichia coli","volume":"25","author":"Lewin","year":"","journal-title":"J. Antimicrob. Chemother."},{"key":"B41","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1099\/00222615-33-2-127","article-title":"Antibacterial activity of fluoroquinolones in combination with zidovudine","volume":"33","author":"Lewin","year":"","journal-title":"J. Med. Microbiol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1016\/j.ijantimicag.2018.08.010","article-title":"Serum bactericidal activity of colistin and azidothymidine combinations against mcr-1-positive colistin-resistant Escherichia coli","volume":"52","author":"Loose","year":"2018","journal-title":"Int. J. Antimicrob. Agents"},{"key":"B43","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1111\/j.1574-695X.1993.tb00377.x","article-title":"In vitro activity of zidovudine alone and in combination with ciprofloxacin against salmonella and Escherichia coli","volume":"7","author":"Mascellino","year":"1993","journal-title":"FEMS Immunol. Med. Microbiol."},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1016\/j.tim.2018.04.004","article-title":"Drug repurposing for viral infectious diseases: how far are we?","author":"Mercorelli","year":"2018","journal-title":"Trends Microbiol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"41","DOI":"10.3389\/fmicb.2019.00041","article-title":"Drug repurposing for the treatment of bacterial and fungal infections","volume":"10","author":"Mir\u00f3-Canturri","year":"2019","journal-title":"Front. Microbiol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/82_2016_499","article-title":"History of antibiotics research","volume":"398","author":"Mohr","year":"2016","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"B47","doi-asserted-by":"crossref","unstructured":"MonacoM.\n            GianiT.\n            RaffoneM.\n            ArenaF.\n            Garcia-FernandezA.\n            PolliniS.\n          Colistin resistance superimposed to endemic carbapenem-resistant Klebsiella pneumoniae: a rapidly evolving problem in Italy, November 2013 to April 2014. Euro Surveill. 192014","DOI":"10.2807\/1560-7917.ES2014.19.42.20939"},{"key":"B48","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/s10096-017-3114-5","article-title":"Repurposing zidovudine in combination with tigecycline for treating carbapenem-resistant Enterobacteriaceae infections","volume":"37","author":"Ng","year":"2018","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"B49","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/j.ijantimicag.2018.01.027","article-title":"New therapy from old drugs: synergistic bactericidal activity of sulfadiazine with colistin against colistin-resistant bacteria, including plasmid-mediated colistin-resistant mcr-1 isolates","volume":"51","author":"Okdah","year":"2018","journal-title":"Int. J. Antimicrob. Agents"},{"key":"B50","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/j.ijantimicag.2014.07.020","article-title":"Worldwide emergence of colistin resistance in Klebsiella pneumoniae from healthy humans and patients in Lao PDR, Thailand, Israel, Nigeria and France owing to inactivation of the PhoP\/PhoQ regulator mgrB: an epidemiological and molecular study","volume":"44","author":"Olaitan","year":"2014","journal-title":"Int. J. Antimicrob. Agents"},{"key":"B51","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.ijantimicag.2018.09.003","article-title":"An alternative strategy for combination therapy: Interactions between polymyxin B and non-antibiotics","volume":"53","author":"Otto","year":"2019","journal-title":"Int. J. Antimicrob. Agents"},{"key":"B52","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1007\/s12010-016-2265-7","article-title":"Control of multidrug-resistant gene flow in the environment through bacteriophage intervention","volume":"181","author":"Parmar","year":"2017","journal-title":"Appl. Biochem. Biotechnol."},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2018.03.012","article-title":"Zidovudine: a salvage therapy for mcr-1 plasmid-mediated colistin-resistant bacterial infections?","author":"Peyclit","year":"2018","journal-title":"Int. J. Antimicrob. Agents"},{"key":"B54","doi-asserted-by":"publisher","first-page":"282","DOI":"10.3389\/fmicb.2015.00282","article-title":"Drug repurposing as an alternative for the treatment of recalcitrant bacterial infections","volume":"6","author":"Rangel-Vega","year":"2015","journal-title":"Front. Microbiol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.nmni.2015.02.007","article-title":"The global threat of antimicrobial resistance: science for intervention","volume":"6","author":"Roca","year":"2015","journal-title":"New Microbes New Infect."},{"key":"B56","doi-asserted-by":"publisher","first-page":"173","DOI":"10.3389\/fmicb.2013.00173","article-title":"Food and human gut as reservoirs of transferable antibiotic resistance encoding genes","volume":"4","author":"Rolain","year":"2013","journal-title":"Front. Microbiol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.cmi.2016.03.026","article-title":"The refusal of the society to accept antibiotic toxicity: missing opportunities for therapy of severe infections","volume":"22","author":"Rolain","year":"2016","journal-title":"Clin. Microbiol. Infect."},{"key":"B58","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1042\/EBC20160058","article-title":"Antibiotic\u2013non-antibiotic combinations for combating extremely drug-resistant gram-negative \u2018superbugs.'","volume":"61","author":"Schneider","year":"2017","journal-title":"Essays Biochem."},{"key":"B59","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1186\/s12906-016-1173-2","article-title":"Antibacterial and antibiotic-resistance modifying activity of the extracts and compounds from Nauclea pobeguinii against gram-negative multi-drug resistant phenotypes","volume":"16","author":"Seukep","year":"2016","journal-title":"BMC Complement. Altern. Med."},{"key":"B60","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.phrs.2017.07.013","article-title":"Drug repurposing in cancer","volume":"124","author":"Sleire","year":"2017","journal-title":"Pharmacol. Res."},{"key":"B61","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.2174\/1568026616666160930131737","article-title":"Repurposing of anticancer drugs for the treatment of bacterial infections","volume":"17","author":"Soo","year":"2017","journal-title":"Curr. Top. Med. Chem."},{"key":"B62","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1086\/420937","article-title":"Trends in Antimicrobial drug development: implications for the future","volume":"38","author":"Spellberg","year":"2004","journal-title":"Clin. Infect. Dis."},{"key":"B63","doi-asserted-by":"publisher","first-page":"17028","DOI":"10.1038\/nmicrobiol.2017.28","article-title":"Pentamidine sensitizes gram-negative pathogens to antibiotics and overcomes acquired colistin resistance","volume":"2","author":"Stokes","year":"2017","journal-title":"Nat. Microbiol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s40246-018-0184-0","article-title":"Identification of drug repurposing candidates based on a miRNA-mediated drug and pathway network for cardiac hypertrophy and acute myocardial infarction","volume":"12","author":"Sun","year":"2018","journal-title":"Hum. Genomics"},{"key":"B65","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1016\/j.drudis.2016.05.015","article-title":"Drug combination therapy increases successful drug repositioning","volume":"21","author":"Sun","year":"","journal-title":"Drug Discov. Today"},{"key":"B66","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/emi.2016.123","article-title":"Rapid antimicrobial susceptibility test for identification of new therapeutics and drug combinations against multidrug-resistant bacteria","volume":"9","author":"Sun","year":"","journal-title":"Emerg. Microbes Infect."},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1016\/j.jgar.2017.11.008","article-title":"Characterization of bla OXA-538, a new variant of bla OXA-48 in shewanella xiamenensis isolated from river water in Algeria","author":"Tafoukt","year":"2017","journal-title":"J. Glob. Antimicrob. Resist."},{"key":"B68","doi-asserted-by":"publisher","first-page":"2458","DOI":"10.3389\/fmicb.2018.02458","article-title":"A novel alkaliphilic streptomyces inhibits ESKAPE pathogens","volume":"9","author":"Terra","year":"2018","journal-title":"Front. Microbiol."},{"key":"B69","doi-asserted-by":"publisher","first-page":"5663","DOI":"10.1128\/AAC.00377-16","article-title":"Screening a commercial library of pharmacologically active small molecules against Staphylococcus aureus biofilms","volume":"60","author":"Torres","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"B70","doi-asserted-by":"publisher","first-page":"721","DOI":"10.3389\/fmicb.2018.00721","article-title":"Novel Polymyxin Combination with antineoplastic mitotane improved the bacterial killing against polymyxin-resistant multidrug-resistant gram-negative pathogens","volume":"9","author":"Tran","year":"2018","journal-title":"Front. Microbiol."},{"key":"B71","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s13756-018-0303-7","article-title":"Synergistic effect of eugenol with Colistin against clinical isolated colistin-resistant Escherichia coli strains","volume":"7","author":"Wang","year":"2018","journal-title":"Antimicrob. Resist. Infect. Control"},{"key":"B72","unstructured":"World Health OrganizationW. H. O.\n          Les 10 principales causes de mortalit\u00e9 (Top 10 causes of death)2018"},{"key":"B73","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/J.IJANTIMICAG.2013.05.011","article-title":"Assessment of the effect of efflux pump inhibitors on in vitro antimicrobial susceptibility of multidrug-resistant Acinetobacter baumannii","volume":"42","author":"Yang","year":"2013","journal-title":"Int. J. Antimicrob. Agents"},{"key":"B74","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.jhin.2015.09.020","article-title":"Characterization of NDM-1- and OXA-23-producing Acinetobacter baumannii isolates from inanimate surfaces in a hospital environment in Algeria","volume":"92","author":"Zenati","year":"2016","journal-title":"J. Hosp. Infect."},{"key":"B75","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1111\/bph.13895","article-title":"Drug repurposing screens and synergistic drug-combinations for infectious diseases","volume":"175","author":"Zheng","year":"2018","journal-title":"Br. J. Pharmacol."},{"key":"B76","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1128\/AAC.02146-17","article-title":"Pterostilbene, a potential MCR-1 inhibitor that enhances the efficacy of polymyxin B","volume":"27","author":"Zhou","year":"2018","journal-title":"Antimicrob. Agents Chemother."}],"container-title":["Frontiers in Cellular and Infection Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fcimb.2019.00193\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,11]],"date-time":"2019-06-11T04:59:50Z","timestamp":1560229190000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fcimb.2019.00193\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,11]]},"references-count":76,"alternative-id":["10.3389\/fcimb.2019.00193"],"URL":"https:\/\/doi.org\/10.3389\/fcimb.2019.00193","relation":{},"ISSN":["2235-2988"],"issn-type":[{"value":"2235-2988","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,11]]},"article-number":"193"}}